News & AnalysisPAQ Therapeutics scores $30m Series APAQ Therapeutics, a biotechnology company, has raised $30 million in Series A financing.ByIris Dorbian15 July 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs